Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pharmacists

The FDA has issued a warning for the drug Gilenya, manufactured by Novartis, approved for the treatment of multiple sclerosis, after a patient died within 24 hours of their first dose due to a brain infection. The FDA has reported that the patient was...
Reuters reports that an article in NEJM has identified possible negative side effects for the approved diabetes drug, Onglyza. Onglyza is a DPP-4 therapy, which blocks dipeptidyl peptidase to help enhance the body’s ability to lower blood sugar...
Reuters reports that Sanofi’s new high dose flu vaccine is more effective at preventing influenza in people over 65 than previously administered lower dose vaccines. The study included 30,000 participants and found that the higher dose vaccine was...